COLON-study Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that influence colorectal tumour recurrence, survival and quality of life
Recruiting
- Conditions
- colorectal cancer10017991
- Registration Number
- NL-OMON32845
- Lead Sponsor
- Wageningen Universiteit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 1000
Inclusion Criteria
All patients, male and female, newly diagnosed with colorectal cancer in any stage of the disease in one of the participating hospitals.
Exclusion Criteria
Non-dutch speaking, history of colorectal tumours or (partial) bowel resection, chronic inflammatory bowel disease, hereditary colorectal cancer syndromes, dementia or order mental condition that makes it impossible to fill out a questionnaire correctly.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primairy outcomes are colorectal cancer recurrence and colorectal adenoma<br /><br>recurrence/occurence. This information will be extracted from hospital<br /><br>registries and the Dutch cancer registries.<br /><br>Quality of life will be assessed with a quality of life questionnaire<br /><br>(EORT-QLQ-C30 in combination with the module for colorectal cancer patients<br /><br>CR-29). </p><br>
- Secondary Outcome Measures
Name Time Method <p>To assess dietary intake and dietary patterns we will ask participants to fill<br /><br>out a food frequency questionnaire.<br /><br>To assess nutritional status, we will analyze the concentration of folate,<br /><br>vitamin D and calcium in blood samples of all participants.<br /><br>We will use surgery reports and hospital data to assess in which patients<br /><br>resurgery is necessary and what the recovery time is.<br /><br>Toxicity of chemo therapy will be assessed with a questionnaire that is part of<br /><br>the regular care of patients who undergo chemo therapy. This will only be<br /><br>submitted to patients who have to undergo chemo therapy. </p><br>